CML announced that, further to the announcement on 2 October 2023, Dr Nathan Zommer has now been appointed to the board of the Company in a non-executive capacity, effective from 1 January 2024, following completion of the normal regulatory due diligence checks.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
418 GBX | +3.21% | +4.50% | +11.76% |
03-26 | CML Microsystems expects revenue growth despite weak trading | AN |
2023 | CML Appoints Dr Nathan Zommer to the Board as Non-Executive, Effective from 1 January 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.76% | 81.61M | |
+82.69% | 2,184B | |
+35.24% | 637B | |
+20.07% | 605B | |
+5.43% | 246B | |
+26.56% | 201B | |
+9.35% | 169B | |
+41.53% | 130B | |
-39.69% | 128B | |
+42.74% | 106B |
- Stock Market
- Equities
- CML Stock
- News CML Microsystems plc
- CML Appoints Dr Nathan Zommer to the Board as Non-Executive, Effective from 1 January 2024